Multiple-Attack Efficacy and Tolerability of Sumatriptan Nasal Spray in the Treatment of Migraine

Archives of Family Medicine

Volumn 7, Issue 3, 1998, Pages 234-240

  Diamond, Seymour ^a   Elkind, Arthur ^b   Jackson, R Terry ^c   Ryan, Robert ^d   DeBussey, Sandy ^e   Asgharnejad, Mahnaz ^e  

^a DIAMOND HEADACHE CLINIC   (United States)

^b Elkind Headache Center   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d Ryan Headache Center   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MIGRAINE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; SEVERITY OF ILLNESS INDEX; SUMATRIPTAN; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0032067764     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.7.3.234     Document Type: Article

References (19)

1. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Eng J Med. 1991;325:316-321.
2. Cady RK, Wendt JK, Kirchner JF, Sargent JD, Rothrock JF, Skaggs H. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991;265:2831-2835.
3. Schoenen J, Bulcke J, Caekebeke J, et al. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study. Cephalalgia. 1994; 14:55-63.
4. The Sumatriptan Auto-Injector Study Group. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol. 1991; 31:323-331.
5. The Oral Sumatriptan Dose-Defining Study Group. Sumatriptan: an oral dose-defining study. Eur Neurol. 1991;31:300-305.
6. The Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol. 1991;31:306-313.
7. Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994:241: 138-144.
8. Cutler N, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology. 1995;45(suppl 7):S5-S9.
9. Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology. 1995;45(suppl 7):S10-S14.
10. Rederich G, Rapoport A, Cutler N, Hazelrigg R, Jamerson B. Oral sumatriptan for the long-term treatment of migraine: clinical findings. Neurology. 1995;45 (suppl 7):S15-S20.
11. Luciani RJ, Osterhaus JT, Gutterman DL. Patient preferences for migraine therapy: Subcutaneous sumatriptan compared with other medications. J Fam Pract. 1995; 41:147-152.
12. Dahlof CGH. How does sumatriptan perform in clinical practice? Cephalalgia. 1995; suppl 15:21-28.
13. Salonen R, Ashford E, Dahlof C, et al. Intranasal sumatriptan for the acute treatment of migraine. J Neurol. 1994;241:463-469.
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1-96.
15. Dechant KL, Clissold FP. Sumatriptan: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992;43:776-798.
16. Fowler PA, Lacey LF, Thomas M, et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31:291-294.
17. Cady RK, Rubino J, Crummett D, Littlejohn T. Oral sumatriptan in the treatment of recurrent headache. Arch Fam Med. 1994;3:766-772.
18. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol. 1991;31:314-322.
19. The Oral Sumatriptan and Aspirin Plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol. 1992;32:177-184.